House passes drug pricing bills amid ObamaCare row

House passes drug pricing bills amid ObamaCare row
© Getty Images

House Democrats on Thursday forced Republicans to vote against their own drug pricing bills by packaging them with measures intended to shore up ObamaCare.

The House passed the package in a 234-183 vote, with Democrats drawing only five Republicans to vote with the majority.

As part of the package, Democrats voted on three bills that would help remove barriers to generic drugs entering the market, and would crack down on tactics that lawmakers say pharmaceutical companies use to tamp down competition and keep prices high.

ADVERTISEMENT

The bills were bipartisan, and passed unanimously out of the Energy and Commerce Committee, but Democratic leaders this week combined them with legislation rolling back some of what they call the administration’s “sabotage” of ObamaCare.

That forced Republicans into the tough position of voting down popular drug pricing bills, so as not to be seen as favoring ObamaCare.

The move was slammed by Republicans for inserting politics into something that has traditionally been bipartisan.

“I have to express my regret that the bipartisan work we did … gets paired up with a purely partisan bill they know we had problems with,” said Rep. Greg WaldenGregory (Greg) Paul WaldenHillicon Valley: Facebook, Twitter dismantle Russian interference campaign targeting African Americans | YouTube to allow ads on coronavirus videos | Trump signs law banning federal funds for Huawei equipment Trump signs law banning use of federal funds to purchase Huawei equipment Trump coronavirus travel ban comes under criticism MORE (R-Ore.), the top Republican on the Energy and Commerce Committee.

“That’s disappointing at best and discouraging and unfortunate, because there’s an opportunity to legislate here,” Walden added.

Republicans had pushed for the drug pricing bills to be separated out from the ObamaCare legislation for a standalone vote.

Adding in the ObamaCare legislation also makes it less likely the GOP-controlled Senate will take up the drug pricing bills.

President TrumpDonald John TrumpDefense industrial base workers belong at home during this public health crisis Maduro pushes back on DOJ charges, calls Trump 'racist cowboy' House leaders hope to vote Friday on coronavirus stimulus MORE, who has made lowering drug prices a key priority, said he supports the drug pricing provisions but would veto the ObamaCare legislation if it ever passed the Senate.

The drug pricing bills included the long-stalled Creates Act, as well as one that would crack down on brand-name drug companies paying generic companies to delay introducing their competing drugs — a practice called “pay-for-delay.”

During a press conference Thursday, House Republican Leader Kevin McCarthyKevin Owen McCarthyHouse leaders hope to vote Friday on coronavirus stimulus House leadership advises members to return to DC as Massie weighs roll call vote on stimulus package Overnight Health Care — Presented by PCMA —US now leads world in known coronavirus cases | Unemployment claims soar by over 3 million | House to vote on stimulus Friday | Ventilator shortage sets off scramble MORE (R-Calif.) decried adding what he said were “partisan poison pills” to legislation where everyone was in agreement.

“They took a situation where we found common ground on drug pricing and transparency … but before they came to the floor, they put poison pills in it dealing with the Affordable Care Act,” McCarthy said.

Democrats said the savings from the three drug pricing bills, which the Congressional Budget Office estimated at $4 billion over the next 10 years, is needed to pay for the ObamaCare bills.

Those bills would ban short-term insurance plans, which Democrats call “junk insurance” plans because they don't have to meet ObamaCare's coverage requirements. The package also includes a bill to restore marketing and outreach funding to help Americans buy insurance through the insurance exchanges.

House Majority Leader Steny HoyerSteny Hamilton HoyerHouse leaders hope to vote Friday on coronavirus stimulus The Hill's Morning Report - Presented by Airbnb - House to pass relief bill; Trump moves to get US back to work House leadership advises members to return to DC as Massie weighs roll call vote on stimulus package MORE (D-Md.) said Democratic leadership forced Republicans into the tough vote on drug pricing in part because of repeated GOP attempts to undermine ObamaCare.

“I think, frankly, we have packaged these bills because we think they are all part and parcel of what we pledged to the American people; that is, bringing down prices and making healthcare available at a level that they need to protect themselves and their families,” Hoyer told reporters Wednesday. “I regret that the administration continues to try to undermine the ACA.”

Rep. Ro KhannaRohit (Ro) KhannaDefense Production Act urgently needed for critical medical gear 20 House Dems call on Trump to issue two-week, nationwide shelter-in-place order Lawmakers call for universal basic income amid coronavirus crisis MORE (D-Calif.) told The Hill he thinks there will be other opportunities for bipartisan work on drug pricing.

"This is important to strengthen the ACA. I don’t have a problem with what leadership is doing," Khanna said.

Updated at 7:50 p.m.